Prostatite aguda

Rothman JR, Jaffe WI. Prostatitis: updates on diagnostic evaluation. Curr Urol Rep. 2007 Jul;8(4):301-6. Resumo

Krieger JN, Lee SW, Jeon J, et al. Epidemiology of prostatitis. Int J Antimicrob Agents. 2008 Feb;31(suppl 1):S85-90.Texto completo  Resumo

European Association of Urology. Guidelines on urological infections. 2022 [internet publication].Texto completo

Nickel JC. Prostatitis. Can Urol Assoc J. 2011 Oct;5(5):306-15.Texto completo  Resumo

National Institute for Health and Care Excellence. Prostatitis (acute): antimicrobial prescribing. Oct 2018 [internet publication].Texto completo

1. Rothman JR, Jaffe WI. Prostatitis: updates on diagnostic evaluation. Curr Urol Rep. 2007 Jul;8(4):301-6. Resumo

2. Krieger JN, Lee SW, Jeon J, et al. Epidemiology of prostatitis. Int J Antimicrob Agents. 2008 Feb;31(suppl 1):S85-90.Texto completo  Resumo

3. Meares EM Jr. Prostatitis. Med Clin North Am. 1991 Mar;75(2):405-24.Texto completo  Resumo

4. Krieger JN, Nyberg L Jr, Nickel JC. NIH consensus definition and classification of prostatitis. JAMA. 1999 Jul 21;282(3):236-7. Resumo

5. Karlovsky ME, Pontari MA. Theories of prostatitis etiology. Curr Urol Rep. 2002 Aug;3(4):307-12. Resumo

6. Potts J, Payne RE. Prostatitis: infection, neuromuscular disorder, or pain syndrome? Proper patient classification is key. Cleve Clin J Med. 2007 May;74(suppl 3):S63-71. Resumo

7. Pontari MA, Joyce GF, Wise M, et al. Prostatitis. J Urol. 2007 Jun;177(6):2050-7. Resumo

8. Gasperi M, Krieger JN, Panizzon MS, et al. Genetic and environmental influences on urinary conditions in men: a classical twin study. Urology. 2019 Jul;129:54-9.Texto completo  Resumo

9. Lipsky BA, Byren I, Hoey CT. Treatment of bacterial prostatitis. Clin Infect Dis. 2010 Jun 15;50(12):1641-52.Texto completo  Resumo

10. Brede CM, Shoskes DA. The etiology and management of acute prostatitis. Nat Rev Urol. 2011 Apr;8(4):207-12.Texto completo  Resumo

11. Workowski KA, Bachmann LH, Chan PA, et al. Sexually Transmitted Infections Treatment Guidelines, 2021. MMWR Recomm Rep. 2021 Jul 23;70(4):1-187.Texto completo  Resumo

12. European Association of Urology. Guidelines on urological infections. 2022 [internet publication].Texto completo

13. Lummus WE, Thompson I. Prostatitis. Emerg Med Clin North Am. 2001 Aug;19(3):691-707. Resumo

14. Terai A, Ishitoya S, Mitsumori K, et al. Molecular epidemiological evidence for ascending urethral infection in acute bacterial prostatitis. J Urol. 2000 Dec;164(6):1945-7. Resumo

15. Weidner W, Schiefer HG, Krauss H, et al. Chronic prostatitis: a thorough search for etiologically involved microorganisms in 1,461 patients. Infection. 1991;19(suppl 3):S119-25. Resumo

16. Meares EM Jr. Prostatitis and related disorders. In: Walsh PC, Retik AB, Vaughan ED, et al, eds. Campbell's urology. 7th ed. Philadelphia, PA: WB Saunders; 1998:615-30.

17. Kumon H. Detection of a local prostatic immune response to bacterial prostatitis. Infection. 1992;20(suppl 3):S236-8. Resumo

18. Schneider H, Ludwig M, Hossain HM, et al. The 2001 Giessen Cohort Study on patients with prostatitis syndrome: an evaluation of inflammatory status and search for microorganisms 10 years after a first analysis. Andrologia. 2003 Oct;35(5):258-62. Resumo

19. Bergman B. On the relevance of gram-positive bacteria in prostatitis. Infection. 1994;22(suppl 1):S22. Resumo

20. Wallner LP, Clemens JQ, Sarma AV. Prevalence of and risk factors for prostatitis in African American men: the Flint Men's Health Study. Prostate. 2009 Jan 1;69(1):24-32. Resumo

21. Kang CI, Kim J, Park DW, et al. Clinical practice guidelines for the antibiotic treatment of community-acquired urinary tract infections. Infect Chemother. 2018 Mar;50(1):67-100.Texto completo  Resumo

22. Karakonstantis S, Kalemaki D. A significant percentage of patients with transrectal biopsy-related infections have positive blood cultures but negative urine cultures. A literature review and meta-analysis. Infect Dis (Lond). 2018 Nov - Dec;50(11-12):791-803.Texto completo  Resumo

23. Seo Y, Lee G. New bacterial infection in the prostate after transrectal prostate biopsy. J Korean Med Sci. 2018 Apr 23;33(17):e126.Texto completo  Resumo

24. Liang CZ, Li HJ, Wang ZP, et al. The prevalence of prostatitis-like symptoms in China. J Urol. 2009 Aug;182(2):558-63. Resumo

25. Moreira DM, Nickel JC, Gerber L, et al. Smoking is associated with acute and chronic prostatic inflammation: results from the REDUCE study. Cancer Prev Res (Phila). 2015 Apr;8(4):312-7.Texto completo  Resumo

26. Nickel JC. Prostatitis. Can Urol Assoc J. 2011 Oct;5(5):306-15.Texto completo  Resumo

27. Coker TJ, Dierfeldt DM. Acute bacterial prostatitis: diagnosis and management. Am Fam Physician. 2016 Jan 15;93(2):114-20.Texto completo  Resumo

28. Zermann DH, Ishigooka M, Doggweiler R, et al. Neurourological insights into the etiology of genitourinary pain in men. J Urol. 1999 Mar;161(3):903-8. Resumo

29. Meares EM, Stamey TA. Bacteriologic localization patterns in bacterial prostatitis and urethritis. Invest Urol. 1968 Mar;5(5):492-518. Resumo

30. Nickel JC, Shoskes D, Wang Y, et al. How does the pre-massage and post-massage 2-glass test compare to the Meares-Stamey 4-glass test in men with chronic prostatitis/chronic pelvic pain syndrome? J Urol. 2006 Jul;176(1):119-24. Resumo

31. Sindhwani P, Wilson CM. Prostatitis and serum prostate-specific antigen. Curr Urol Rep. 2005 Jul;6(4):307-12. Resumo

32. Stopiglia RM, Ferreira U, Silva MM Jr, et al. Prostate specific antigen decrease and prostate cancer diagnosis: antibiotic versus placebo prospective randomized clinical trial. J Urol. 2010 Mar;183(3):940-4. Resumo

33. Nickel JC, Ardern D, Downey J. Cytologic evaluation of urine is important in evaluation of chronic prostatitis. Urology. 2002 Aug;60(2):225-7. Resumo

34. Langer JE, Cornud F. Inflammatory disorders of the prostate and the distal genital tract. Radiol Clin North Am. 2006 Sep;44(5):665-77. Resumo

35. Wasserman NF. Prostatitis: clinical presentations and transrectal ultrasound findings. Semin Roentgenol. 1999 Oct;34(4):325-37. Resumo

36. Ackerman AL, Parameshwar PS, Anger JT. Diagnosis and treatment of patients with prostatic abscess in the post-antibiotic era. Int J Urol. 2018 Feb;25(2):103-10.Texto completo  Resumo

37. Zaidi S, Gandhi J, Seyam O, et al. Etiology, diagnosis, and management of seminal vesicle stones. Curr Urol. 2019 May 10;12(3):113-20.Texto completo  Resumo

38. Lee JC, Muller CH, Rothman I, et al. Prostate biopsy culture findings of men with chronic pelvic pain syndrome do not differ from those of healthy controls. J Urol. 2003 Feb;169(2):584-7. Resumo

39. Collins MM, Stafford RS, O'Leary MP, et al. How common is prostatitis? A national survey of physician visits. J Urol. 1998 Apr;159(4):1224-8. Resumo

40. Schiller DS, Parikh A. Identification, pharmacologic considerations, and management of prostatitis. Am J Geriatr Pharmacother. 2011 Feb;9(1):37-48. Resumo

41. Ludwig M. Diagnosis and therapy of acute prostatitis, epididymitis and orchitis. Andrologia. 2008 Apr;40(2):76-80.Texto completo  Resumo

42. National Institute for Health and Care Excellence. Prostatitis (acute): antimicrobial prescribing. Oct 2018 [internet publication].Texto completo

43. European Medicines Agency. Quinolone- and fluoroquinolone-containing medicinal products. Mar 2019 [internet publication].Texto completo

44. Medicines and Healthcare products Regulatory Agency. Fluoroquinolone antibiotics: new restrictions and precautions for use due to very rare reports of disabling and potentially long-lasting or irreversible side effects. Mar 2019 [internet publication].Texto completo

45. US Food and Drug Administration. FDA drug safety communication: FDA advises restricting fluoroquinolone antibiotic use for certain uncomplicated infections; warns about disabling side effects that can occur together. Sept 2018 [internet publication].Texto completo

46. US Food and Drug Administration. FDA warns about increased risk of ruptures or tears in the aorta blood vessel with fluoroquinolone antibiotics in certain patients. Dec 2018 [internet publication].Texto completo

47. US Food and Drug Administration. FDA reinforces safety information about serious low blood sugar levels and mental health side effects with fluoroquinolone antibiotics; requires label changes. Oct 2018 [internet publication].Texto completo

48. Barbalias GA, Nikiforidis G, Liatsikos EN. Alpha-blockers for the treatment of chronic prostatitis in combination with antibiotics. J Urol. 1998 Mar;159(3):883-7. Resumo

49. Schaeffer AJ. Prostatitis: US perspective. Int J Antimicrob Agents. 1999 May;11(3-4):205-11. Resumo

50. European Medicines Agency. Disabling and potentially permanent side effects lead to suspension or restrictions of quinolone and fluoroquinolone antibiotics. Nov 2018 [internet publication].Texto completo

51. Sahin A, Eiley D, Goldfischer ER, et al. The in vitro bactericidal effect of microwave energy on bacteria that cause prostatitis. Urology. 1998 Sep;52(3):411-5. Resumo

52. Nickel JC, Sorenson R. Transurethral microwave thermotherapy for nonbacterial prostatitis: a randomized double-blind sham controlled study using new prostatitis specific assessment questionnaires. J Urol. 1996 Jun;155(6):1950-4. Resumo

53. Rees J, Abrahams M, Doble A, et al. Diagnosis and treatment of chronic bacterial prostatitis and chronic prostatitis/chronic pelvic pain syndrome: a consensus guideline. BJU Int. 2015 Oct;116(4):509-25.Texto completo  Resumo

54. Abdelmoteleb H, Rashed F, Hawary A. Management of prostate abscess in the absence of guidelines. Int Braz J Urol. 2017 Sep-Oct;43(5):835-40.Texto completo  Resumo

55. Franco JV, Turk T, Jung JH, et al. Pharmacological interventions for treating chronic prostatitis/chronic pelvic pain syndrome. Cochrane Database Syst Rev. 2019 Oct 6;10:CD012552.Texto completo  Resumo

56. Bowen DK, Dielubanza E, Schaeffer AJ. Chronic bacterial prostatitis and chronic pelvic pain syndrome. BMJ Clin Evid. 2015 Aug 27;2015.Texto completo  Resumo